Compounded semaglutide
Sold by TD Tele-Doc Weight Loss · Injection, vial · every compounded semaglutide record
Recorded initial charges
First month
$199
first month, including required fees on record. The published monthly rate excludes one-time and annual fees; introductory and conditional rates may change. Some fee details are unverified or unpublished; this sum does not establish the full amount payable.
| Medication · Starting price · recorded initial monthly payment | $199 |
|---|
Added from the figures recorded below.
Price
| Term | Per month | Charged today |
|---|---|---|
| Starting price “SEMAGLUTIDE Possible Benefits: A weight loss game changer! • Suppress your appetite • Proactively Lower Your Blood sugar • Decrease Risk of Diabetes STARTING AT $199” | Per month$199 | Charged today$199 |
Price sources
- Starting price · tdteledocweightloss.com — read September 2026
We earn nothing from this link. It opens TD Tele-Doc Weight Loss's website without a paid referral.
History
Fewer than two comparable calendar-month readings are available for a price trend. Day- or week-based supplies, introductory offers and unverified payment terms are not connected in this chart.
- September 2026 — Entry added to the register
Sourcing and terms
| States | Virginia |
|---|---|
| Prescriber | Live visit |
Not yet checked: pharmacy, cancellation, membership and consult fee.
Recorded from tdteledocweightloss.com. Unlike the price rows above, these carry a summary rather than a word-for-word quotation, so they are not shown in quotation marks.
Notes
- 1. September 2026 — This is a small physical clinic (Peter Wilbanks, MD and Michael Perini, MD) in Virginia offering telemedicine only within the state, not a national telehealth platform -- confirmed explicitly ('exclusively to residents of Virginia'). Only a single starting price ($199) for Semaglutide is published; no Tirzepatide-specific dollar figure was found despite Tirzepatide having its own dedicated section of the medications page. One patient testimonial mentions 'semaglutide drops,' which would imply a sublingual form, but this is not corroborated anywhere in the company's own product description (which instead describes Semaglutide as 'compounded Semaglutide injections'), so form is recorded as injection-vial (compounded injection) with the 'drops' claim noted here rather than used to override the site's own product description. No cancellation or refund policy text was reachable through this tool (terms-and-conditions and appointment pages are JS-rendered with no server-side text).
Treatment Registry is an independent editorial record. It is not a government registry, a licensing body, or a certification. An entry means we recorded what a company published on a given date. It does not mean we recommend the program, and it does not mean the program is approved by anyone.